It was first directly demonstrated that CD8+ T cells promote cancer relapse by inducing EMT-mediated immunoediting in cancer by Radisky’s group.25 They transplanted epithelial tumors expressing neo-antigens into syngeneic mice and observed T cell-dependent rejection, but subsequently, an unexpected relapse. The gene discussed is CD8A; the disease is cancer.